Intuitive Surgical placed 468 da Vinci systems in the most recent quarter, an 18% increase from 395 a year earlier, with U.S. placements up 24% year-over-year. The acceleration is led by strong demand for the new da Vinci 5 platform, and recurring revenue now accounts for 85% of total revenue. The installed base grew 12% globally last quarter, expanding the foundation for future high-margin instrument and service sales. The company's stock is down 21% over the last year on concerns about slowing U.S. procedure growth, but hospital capital commitments suggest customers view the softness as temporary.
Intuitive Surgical IncStrong demand for da Vinci 5 drives 18% system placement increase and 24% US growth
Globus Medical
Medtronic PLC
Stryker Corporation
Zimmer Biomet Holdings Inc